Literature DB >> 31883879

Urinary Diversion Disparity Following Radical Cystectomy for Bladder Cancer in the Hispanic Population.

Emily M Rios1, Mitchell A Parma1, Roman A Fernandez2, Timothy N Clinton1, Ryan M Reyes3, Dharam Kaushik1, Deepak Pruthi1, Ahmed M Mansour1, Neelam Mukherjee4, Jon Gelfond2, Karen M Wheeler1, Robert S Svatek5.   

Abstract

OBJECTIVE: To determine if disparities in quality of surgical care exist between Hispanics and non-Hispanics undergoing radical cystectomy for bladder cancer.
MATERIALS AND METHODS: An observational cohort study was conducted retrospectively on patients who underwent radical cystectomy for urothelial carcinoma of the bladder at our institution between January 2005 and July 2018. Data was collected on demographic, clinical, and pathological characteristics of patients, including self-reported ethnicity. Univariable and multivariable logistic or linear regression analyses were used to evaluate the association of ethnicity with receipt of neoadjuvant chemotherapy, utilization of laparoscopic surgery, number of lymph nodes removed, and continent urinary diversion.
RESULTS: We identified 507 patients in our database out of which, 136 (27%) were Hispanic and 371 (73%) were non-Hispanic. Compared to non-Hispanics, Hispanics had a higher body mass index (26.9 kg/m2 vs 28.2 kg/m2, P = .006) and lived further away from site of surgery (34 vs 96 miles, P = .02). No significant differences were observed in receipt of neoadjuvant chemotherapy, laparoscopic surgery, or number of lymph nodes removed during cystectomy between ethnicity groups. However, Hispanics were less likely than non-Hispanics to receive a continent urinary diversion on multivariable analysis (odds ratio 0.30, 95% confidence interval 0.10 - 0.92, P = .03).
CONCLUSION: Disparity exists in the delivery of continent urinary diversions for Hispanic patients undergoing radical cystectomy for bladder cancer. Further investigation is needed to determine the potential causes for this disparity in care delivered.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31883879      PMCID: PMC7063861          DOI: 10.1016/j.urology.2019.12.017

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  25 in total

Review 1.  Racial and ethnic disparities in the receipt of cancer treatment.

Authors:  Vickie L Shavers; Martin L Brown
Journal:  J Natl Cancer Inst       Date:  2002-03-06       Impact factor: 13.506

2.  Reasons for underuse of recommended therapies for colorectal and lung cancer in the Veterans Health Administration.

Authors:  Mary Beth Landrum; Nancy L Keating; Elizabeth B Lamont; Samuel R Bozeman; Barbara J McNeil
Journal:  Cancer       Date:  2011-11-09       Impact factor: 6.860

3.  The causal pathways linking health literacy to health outcomes.

Authors:  Michael K Paasche-Orlow; Michael S Wolf
Journal:  Am J Health Behav       Date:  2007 Sep-Oct

4.  The Clavien-Dindo classification of surgical complications: five-year experience.

Authors:  Pierre A Clavien; Jeffrey Barkun; Michelle L de Oliveira; Jean Nicolas Vauthey; Daniel Dindo; Richard D Schulick; Eduardo de Santibañes; Juan Pekolj; Ksenija Slankamenac; Claudio Bassi; Rolf Graf; René Vonlanthen; Robert Padbury; John L Cameron; Masatoshi Makuuchi
Journal:  Ann Surg       Date:  2009-08       Impact factor: 12.969

5.  Racial disparities in outcomes of spinal surgery for lumbar stenosis.

Authors:  Shivanand P Lad; Jacob H Bagley; Krista T Kenney; Beatrice Ugiliweneza; Maiying Kong; Carlos A Bagley; Oren N Gottfried; Robert E Isaacs; Chirag G Patil; Maxwell Boakye
Journal:  Spine (Phila Pa 1976)       Date:  2013-05-15       Impact factor: 3.468

6.  Health disparities: a barrier to high-quality care.

Authors:  C Daniel Mullins; Lisa Blatt; Confidence M Gbarayor; Hui-Wen Keri Yang; Claudia Baquet
Journal:  Am J Health Syst Pharm       Date:  2005-09-15       Impact factor: 2.637

7.  Racial differences in trust and lung cancer patients' perceptions of physician communication.

Authors:  Howard S Gordon; Richard L Street; Barbara F Sharf; P Adam Kelly; Julianne Souchek
Journal:  J Clin Oncol       Date:  2006-02-20       Impact factor: 44.544

8.  Discrepancies in staging, treatment, and delays to treatment may explain disparities in bladder cancer outcomes: An update from the National Cancer Data Base (2004-2013).

Authors:  Adam B Weiner; Mary-Kate Keeter; Adarsh Manjunath; Joshua J Meeks
Journal:  Urol Oncol       Date:  2018-01-12       Impact factor: 3.498

Review 9.  Defining, measuring, and improving surgical quality: beyond teamwork and checklists to systems redesign and transformation.

Authors:  Carla C Braxton
Journal:  Surg Infect (Larchmt)       Date:  2012-11-01       Impact factor: 2.150

10.  Disparities in the Use of Continent Urinary Diversions after Radical Cystectomy for Bladder Cancer.

Authors:  Nicholas J Farber; Izak Faiena; Viktor Dombrovskiy; Alexandra L Tabakin; Brian Shinder; Rutveej Patel; Sammy E Elsamra; Thomas L Jang; Eric A Singer; Robert E Weiss
Journal:  Bladder Cancer       Date:  2018-01-20
View more
  1 in total

1.  lncRNA-UCA1 in the diagnosis of bladder cancer: A meta-analysis.

Authors:  Zhenshan Ding; Wenwei Ying; Yuhui He; Xing Chen; Yangtian Jiao; Jianfeng Wang; Xiaofeng Zhou
Journal:  Medicine (Baltimore)       Date:  2021-03-19       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.